CycloSPORINE 0.05 % Ophthalmic Emulsion
RxNorm 351291
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 351291 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cycloSPORINE 0.05 % Ophthalmic Emulsion.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Cyclosporine 0.5 mg/ML Ophthalmic Suspension
(Atom ID: 12326018)
SYPrescribable
Synonym (SY):
Ciclosporin 500 microgram/mL eye suspension
(Atom ID: 11435941)
PSNPrescribable
Prescribable Name (PSN):
CycloSPORINE 0.05 % Ophthalmic Emulsion
(Atom ID: 6406679)
SYPrescribable
Synonym (SY):
Cyclosporine 0.05 % Ophthalmic Emulsion
(Atom ID: 6407814)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
CycloSPORINE 0.05 % Ophthalmic Emulsion
(Atom ID: 6408288)
SYPrescribable
Synonym (SY):
Cyclosporine 0.05 % Ophthalmic Suspension
(Atom ID: 3056856)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
CycloSPORINE 0.05 % Ophthalmic Suspension
(Atom ID: 3725576)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
CycloSPORINE 0.5 mg/ML Ophthalmic Suspension
(Atom ID: 3734364)
PTPrescribable
Designated preferred name (PT):
Cyclosporine 500 microgram/mL eye suspension
(Atom ID: 11436148)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely ciclosporin 500 microgram/1 mL conventional release eye suspension (clinical drug)
(Atom ID: 11439532)
Patient Education
Cyclosporine Ophthalmic
Ophthalmic cyclosporine is used to increase tear production in people with dry eye disease. Cyclosporine is in a class of medications called immunomodulators. It works by decreasing swelling in the eye to allow for tear production.
[Learn More]
* Please review the disclaimer below.